Immunicon Corporation Cuts 40% of Staff, Sees Q1 Charge

March 10 (Reuters) - Immunicon Corp said it was cutting about 40 percent of its full-time staff after it lost an arbitration with a Johnson & Johnson unit to end a marketing agreement for its cancer diagnostic products.